Highlights
The global Non-invasive Continuous Glucose Monitor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Non-invasive Continuous Glucose Monitor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Non-invasive Continuous Glucose Monitor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Non-invasive Continuous Glucose Monitor include Dexcom, Abbott Laboratories, Medtronic, Senseonics Holdings, Know Labs, Huzhou Meiqi Medical Devices, San Meditech, Roche and LifeScan, Inc., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-invasive Continuous Glucose Monitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Continuous Glucose Monitor.
The Non-invasive Continuous Glucose Monitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-invasive Continuous Glucose Monitor market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-invasive Continuous Glucose Monitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
Know Labs
Huzhou Meiqi Medical Devices
San Meditech
Roche
LifeScan, Inc.
Insulet Corporation
Panasonic
Echo Therapeutics
Tandem Diabetes Care
Segment by Type
Wearable
Not wearable
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-invasive Continuous Glucose Monitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-invasive Continuous Glucose Monitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Non-invasive Continuous Glucose Monitor Market Overview
1.1 Product Overview and Scope of Non-invasive Continuous Glucose Monitor
1.2 Non-invasive Continuous Glucose Monitor Segment by Type
1.2.1 Global Non-invasive Continuous Glucose Monitor Market Value Comparison by Type (2023-2029)
1.2.2 Wearable
1.2.3 Not wearable
1.3 Non-invasive Continuous Glucose Monitor Segment by Application
1.3.1 Global Non-invasive Continuous Glucose Monitor Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-invasive Continuous Glucose Monitor Market Size Estimates and Forecasts
1.4.1 Global Non-invasive Continuous Glucose Monitor Revenue 2018-2029
1.4.2 Global Non-invasive Continuous Glucose Monitor Sales 2018-2029
1.4.3 Global Non-invasive Continuous Glucose Monitor Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-invasive Continuous Glucose Monitor Market Competition by Manufacturers
2.1 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-invasive Continuous Glucose Monitor Average Price by Manufacturers (2018-2023)
2.4 Global Non-invasive Continuous Glucose Monitor Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-invasive Continuous Glucose Monitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-invasive Continuous Glucose Monitor, Product Type & Application
2.7 Non-invasive Continuous Glucose Monitor Market Competitive Situation and Trends
2.7.1 Non-invasive Continuous Glucose Monitor Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-invasive Continuous Glucose Monitor Players Market Share by Revenue
2.7.3 Global Non-invasive Continuous Glucose Monitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-invasive Continuous Glucose Monitor Retrospective Market Scenario by Region
3.1 Global Non-invasive Continuous Glucose Monitor Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-invasive Continuous Glucose Monitor Global Non-invasive Continuous Glucose Monitor Sales by Region: 2018-2029
3.2.1 Global Non-invasive Continuous Glucose Monitor Sales by Region: 2018-2023
3.2.2 Global Non-invasive Continuous Glucose Monitor Sales by Region: 2024-2029
3.3 Global Non-invasive Continuous Glucose Monitor Global Non-invasive Continuous Glucose Monitor Revenue by Region: 2018-2029
3.3.1 Global Non-invasive Continuous Glucose Monitor Revenue by Region: 2018-2023
3.3.2 Global Non-invasive Continuous Glucose Monitor Revenue by Region: 2024-2029
3.4 North America Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
3.4.1 North America Non-invasive Continuous Glucose Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-invasive Continuous Glucose Monitor Sales by Country (2018-2029)
3.4.3 North America Non-invasive Continuous Glucose Monitor Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
3.5.1 Europe Non-invasive Continuous Glucose Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-invasive Continuous Glucose Monitor Sales by Country (2018-2029)
3.5.3 Europe Non-invasive Continuous Glucose Monitor Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
3.6.1 Asia Pacific Non-invasive Continuous Glucose Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
3.7.1 Latin America Non-invasive Continuous Glucose Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-invasive Continuous Glucose Monitor Sales by Country (2018-2029)
3.7.3 Latin America Non-invasive Continuous Glucose Monitor Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-invasive Continuous Glucose Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-invasive Continuous Glucose Monitor Sales by Type (2018-2029)
4.1.1 Global Non-invasive Continuous Glucose Monitor Sales by Type (2018-2023)
4.1.2 Global Non-invasive Continuous Glucose Monitor Sales by Type (2024-2029)
4.1.3 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2018-2029)
4.2 Global Non-invasive Continuous Glucose Monitor Revenue by Type (2018-2029)
4.2.1 Global Non-invasive Continuous Glucose Monitor Revenue by Type (2018-2023)
4.2.2 Global Non-invasive Continuous Glucose Monitor Revenue by Type (2024-2029)
4.2.3 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2018-2029)
4.3 Global Non-invasive Continuous Glucose Monitor Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-invasive Continuous Glucose Monitor Sales by Application (2018-2029)
5.1.1 Global Non-invasive Continuous Glucose Monitor Sales by Application (2018-2023)
5.1.2 Global Non-invasive Continuous Glucose Monitor Sales by Application (2024-2029)
5.1.3 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2018-2029)
5.2 Global Non-invasive Continuous Glucose Monitor Revenue by Application (2018-2029)
5.2.1 Global Non-invasive Continuous Glucose Monitor Revenue by Application (2018-2023)
5.2.2 Global Non-invasive Continuous Glucose Monitor Revenue by Application (2024-2029)
5.2.3 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2018-2029)
5.3 Global Non-invasive Continuous Glucose Monitor Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Dexcom
6.1.1 Dexcom Corporation Information
6.1.2 Dexcom Description and Business Overview
6.1.3 Dexcom Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Dexcom Non-invasive Continuous Glucose Monitor Product Portfolio
6.1.5 Dexcom Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Laboratories Non-invasive Continuous Glucose Monitor Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Non-invasive Continuous Glucose Monitor Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Senseonics Holdings
6.4.1 Senseonics Holdings Corporation Information
6.4.2 Senseonics Holdings Description and Business Overview
6.4.3 Senseonics Holdings Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Senseonics Holdings Non-invasive Continuous Glucose Monitor Product Portfolio
6.4.5 Senseonics Holdings Recent Developments/Updates
6.5 Know Labs
6.5.1 Know Labs Corporation Information
6.5.2 Know Labs Description and Business Overview
6.5.3 Know Labs Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Know Labs Non-invasive Continuous Glucose Monitor Product Portfolio
6.5.5 Know Labs Recent Developments/Updates
6.6 Huzhou Meiqi Medical Devices
6.6.1 Huzhou Meiqi Medical Devices Corporation Information
6.6.2 Huzhou Meiqi Medical Devices Description and Business Overview
6.6.3 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Product Portfolio
6.6.5 Huzhou Meiqi Medical Devices Recent Developments/Updates
6.7 San Meditech
6.6.1 San Meditech Corporation Information
6.6.2 San Meditech Description and Business Overview
6.6.3 San Meditech Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 San Meditech Non-invasive Continuous Glucose Monitor Product Portfolio
6.7.5 San Meditech Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Roche Non-invasive Continuous Glucose Monitor Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 LifeScan, Inc.
6.9.1 LifeScan, Inc. Corporation Information
6.9.2 LifeScan, Inc. Description and Business Overview
6.9.3 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.9.4 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Product Portfolio
6.9.5 LifeScan, Inc. Recent Developments/Updates
6.10 Insulet Corporation
6.10.1 Insulet Corporation Corporation Information
6.10.2 Insulet Corporation Description and Business Overview
6.10.3 Insulet Corporation Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Insulet Corporation Non-invasive Continuous Glucose Monitor Product Portfolio
6.10.5 Insulet Corporation Recent Developments/Updates
6.11 Panasonic
6.11.1 Panasonic Corporation Information
6.11.2 Panasonic Non-invasive Continuous Glucose Monitor Description and Business Overview
6.11.3 Panasonic Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Panasonic Non-invasive Continuous Glucose Monitor Product Portfolio
6.11.5 Panasonic Recent Developments/Updates
6.12 Echo Therapeutics
6.12.1 Echo Therapeutics Corporation Information
6.12.2 Echo Therapeutics Non-invasive Continuous Glucose Monitor Description and Business Overview
6.12.3 Echo Therapeutics Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Echo Therapeutics Non-invasive Continuous Glucose Monitor Product Portfolio
6.12.5 Echo Therapeutics Recent Developments/Updates
6.13 Tandem Diabetes Care
6.13.1 Tandem Diabetes Care Corporation Information
6.13.2 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Description and Business Overview
6.13.3 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Product Portfolio
6.13.5 Tandem Diabetes Care Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-invasive Continuous Glucose Monitor Industry Chain Analysis
7.2 Non-invasive Continuous Glucose Monitor Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-invasive Continuous Glucose Monitor Production Mode & Process
7.4 Non-invasive Continuous Glucose Monitor Sales and Marketing
7.4.1 Non-invasive Continuous Glucose Monitor Sales Channels
7.4.2 Non-invasive Continuous Glucose Monitor Distributors
7.5 Non-invasive Continuous Glucose Monitor Customers
8 Non-invasive Continuous Glucose Monitor Market Dynamics
8.1 Non-invasive Continuous Glucose Monitor Industry Trends
8.2 Non-invasive Continuous Glucose Monitor Market Drivers
8.3 Non-invasive Continuous Glucose Monitor Market Challenges
8.4 Non-invasive Continuous Glucose Monitor Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
Know Labs
Huzhou Meiqi Medical Devices
San Meditech
Roche
LifeScan, Inc.
Insulet Corporation
Panasonic
Echo Therapeutics
Tandem Diabetes Care
*If Applicable.